Abstract: Directed evolution of oxidoreductases to improve their catalytic properties is being ardently pursued in the industrial, biotechnological, and biopharma sectors. Hampering this pursuit are current enzyme screening methods that are limited in terms of throughput, cost, time and complexity. We present a directed evolution strategy that allows for large-scale one-pot screening of glucose oxidase (GOx) enzyme libraries in well-mixed homogeneous solution. We used GOx variants displayed on the outer cell wall of yeasts to initiate a cascade reaction with horseradish peroxidase (HRP), resulting in peroxidase-mediated phenol cross-coupling and encapsulation of individual cells in well-defined fluorescent alginate hydrogel shells within ~10 minutes in mixed cell suspensions. Following application of denaturing stress to whole-cell GOx libraries, only cells displaying GOx variants with enhanced stability or catalytic activity were able to carry out the hydrogel encapsulation reaction. Fluorescence activated cell sorting was then used to isolate the enhanced variants. We characterized three of the newly evolved Aspergillus niger GOx enzyme sequences and found up to ~5-fold higher specific activity, enhanced thermal stability, and differentiable glycosylation patterns. By coupling intracellular gene expression with the rapid formation of an extracellular hydrogel capsule, our system improves high-throughput screening for directed evolution of H2O2-producing enzymes many fold.
Introduction
Reaction compartmentalization at the cellular length scale is of high interest for directed evolution (Fischlechner et al., 2014; Sjostrom et al., 2014; Tawfik and Griffiths, 1998) . The goal in such experiments is to combine the generation of genetic diversity together with screening or selection for enhanced phenotypic traits. Such approaches have been widely used for improving the performance of affinity proteins such as antibodies, as well as catalytic enzymes (Arnold, 2018; Denard et al., 2015; Jeschek et al., 2016; Packer and Liu, 2015; Powell et al., 2001; Taylor et al., 2001) . Typically, screening for improved enzymatic activity is achievable only at low-to-medium throughput (<10 4 variants) because each enzyme variant has to be assayed individually, which can be time consuming and costly. Typically, each clone is isolated and grown in a separate well of a multi-well plate or in a separate colony on an agar plate. Each individual wells or colony then serves as reaction compartment which restricts diffusion of the enzyme reaction products localizing them to the site of production. This spatial co-localization allows for the necessary genotype-phenotype linkage for directed evolution to proceed. However, the requirement of separating genetic clones into different reaction compartments severely restricts the throughput of enzyme screens. This ultimately limits the size of the genetic libraries that can be screened, slowing down the evolutionary process. To address this shortcoming, various methods for microscale reaction compartmentalization have been developed, including single and double emulsions (Griffiths and Tawfik, 2006) , and multi-phase microfluidic systems for droplet generation (Colin et al., 2015; Kintses et al., 2012) . Multi-phase systems, however, may be cumbersome to implement, often requiring microfabricated devices and precise flow rate control. Furthermore, many droplet systems rely on cell-free transcription/translation, which may not be capable of glycosylation and other post-translational modifications that can affect protein activity, or may lack folding chaperones.
The cell surface has also been utilized as a quasi-compartment. In such systems, bacteria can be labelled with fluorescent molecules or hydrogels when a target reaction occurs inside the cell (Lülsdorf et al., 2015) , or when displayed enzymes covalently modify the cell surface. Such approaches have been used, for example, to evolve peptide ligases (Chen et al., 2011) and oxidoreductases using a tyramide-fluorescein assay (Lipovsek et al., 2007; Ostafe et al., 2014) . Although covalent cell-surface modification with small molecules offers some improvements, such systems can suffer from cross-reactivity between positive and negative cells, increasing the false-positive rate.
Directed evolution of accelerated or stabilized GOx variants is of considerable interest for the food and textile industries, as well as for blood glucose detection (Wong et al., 2008) , deoxygenation of buffers for single-molecule fluorescence applications (Aitken et al., 2008) , and oxygen inhibitor removal for radical polymerization (Chapman et al., 2014) . Recently we reported a new method for single-cell encapsulation in hydrogel capsules that relied on a glucose oxidase (GOx) and horseradish peroxidase (HRP) enzyme cascade to cross-link phenol moieties grafted onto alginate and chitosan macromonomers (Vanella et al., 2019) . The system we reported was made possible by GOx initiator enzymes that were synthesized by the cells from single-copy plasmids carrying the GOx gene, and surface-displayed on the outer cell wall. A competing approach has also been reported to produce hydrogels using a GOx cascade with Fenton's reagent, which can produce hydroxyl radicals for polymerization of vinylated compounds and fluorophores (Malinowska et al., 2014; Malinowska et al., 2015; Malinowska and Nash, 2016; Pitzler et al., 2014) . Here, we report the utilization of the GOx-mediated cell encapsulation system for directed evolution of GOx. We utilized the GOx/HRP cell encapsulation system for screening of residual GOx activity following denaturing stress applied to a library of mutant GOx enzymes. Our strategy utilizes enzymatic radical polymerization to form a well defined uniform hydrogel shell around cells presenting active variants of the target enzyme. The 3D conformal nature of the hydrogel shells and the short lifetimes of the radical cross-linking species are features that allowed for essentially zero cross-reactivity (i.e., no false positive labelling) under our optimized conditions. The resultant GOx variants were isolated in soluble form and characterized using biophysical assays to shed light on the mechanisms involved in thermal and catalytic enhancement.
Materials and Methods
Materials. All the chemicals used in this work were purchased from Sigma Aldrich if not otherwise specified.
The primary and secondary antibodies were purchased from Thermo Fisher Scientific. Restriction enzymes were purchased from New England Biolabs. Sodium Alginate (Viscosity 1%: 100 -200 mPa⋅s) was purchased from Duchefa Biochemie.
Amplification, cloning, and yeast display of WT GOx. The GOx wild type gene was amplified from the genome of Aspergillus niger strain 4247 (LGC Standards) using the primers F1 and R1 (Table 1) , and cloned using BamHI and XhoI restriction sites into the yeast plasmid pYD1 for protein display (gift from Dane Wittrup, Addgene plasmid #73447) (Kieke et al., 1997) . After sequence confirmation, the plasmid pYD1-GOx was transformed into Saccharomyces cerevisiae EBY100 following a typical lithium acetate transformation (Gietz and Woods, 2002) procedure, followed by selection of positive colonies on SD agar 2% (w/v) glucose plates lacking tryptophan (-Trp). Resulting colonies were cultivated in -Trp liquid medium with 2% glucose for 24 hours at 30°C to an OD600 ~8 with continuous shaking at 200 rpm. Protein expression and display was then induced by transferring the culture at a starting OD600 ~0.4 to fresh liquid medium lacking tryptophan containing 0.2% (w/v) glucose and 1.8% (w/v) galactose, and shaking for 24 hours at 30°C.
Preparation of fluorescent alginate with phenols groups. Alginate macromonomers grafted with phenol moieties and aminofluorescein was prepared through carbodiimide activation chemistry as previously reported (Sakai and Kawakami, 2007; Vanella et al., 2019) . Sodium alginate (avg. MW 70,000 Da) was dissolved in 50 mM MES buffer pH 6 (10 mg/mL), followed by addition of tyramine hydrochloride, NHS, and EDC at concentrations of 7, 1.2, and 3.9 mg/mL, respectively. Finally, 0.25 mg/mL of 6-aminofluorescein was added and the reaction was allowed to proceed at room temperature for ~18 hours with stirring. The modified alginate was then precipitated dropwise into an 80% ethanol solution in water, followed washing with 80% ethanol.
The final product was dissolved in water prior to lyophilization. Modification was confirmed through 1 H-
NMR.
Cell encapsulation in fluorescent alginate hydrogels. Yeast cells in induction media displaying GOx were washed with 50 mM sodium phosphate buffer pH 7.4 and resuspended at OD600 = 0.2 (~2 10 6 cells/mL).
Glucose (100 mM), HRP (4.5 µM) and modified alginate (0.125% (w/v)) were added. The reaction was gently mixed and incubated at room temperature for 10 min, followed by four fold dilution by 50 mM sodium phosphate buffer pH 7.4. Samples were then analyzed through fluorescence microscopy or flow cytometry.
GOx mutant library construction by error prone PCR.
A GOx mutant library with a medium mutation frequency (4.5-9 mutations/ kb) was prepared by amplifying the region between nucleotides 4 and 513 of the GOx wild type gene in pYD1 through error prone PCR (GeneMorph II, Agilent) using primers F2 and R2
( Table 1 ). The backbone of the recipient vector was amplified through PCR using primers F3 and R3 ( Table   1 ). The error prone PCR product and the pYD1 linearized backbone were then co-transformed into EBY100
an assembled as a complete plasmid in vivo via gap repair (Oldenburg et al., 1997) . After culturing of the positive clones on selective medium agar plates, the colonies were collected and grown for 24 hours in liquid media prior to induction of GOx expression and display.
FACS-based screening. Yeast cells were sorted using a MoFLo XDP cell sorter from Beckman Coulter equipped with 488 nm and 561 nm lasers, and with a 100 µm nozzle. Prior to sorting, GOx mutant libraries were treated with 5M guanidinium chloride for 10 minutes, washed 3 times, and stained with Propidium Iodide (final concentration of 4 µg/mL), followed by washing. Next, the same PI-stained cells were used for the encapsulation reaction under the following conditions: ~2 10 6 cells/mL suspended in 50 mM sodium phosphate buffer, pH 7.4. Glucose, HRP and modified alginate were used at final concentrations of 100 mM, fractions and all samples were tested for GOx activity using an ABTS assay (see below). Eluted fractions containing functional GOx were isolated and concentrated through a 100 kDa cutoff Vivaspin ultrafiltration column. Different GOx variants were compared in there native, denatured and deglycosylated using SDS-PAGE. In order to cleave N-linked mannose and compare the proteins in their deglycosylated form, each protein (1µg) was denatured and treated with 1000 units of EndoH (NEB) enzyme at 37°C for 1h.
Enzyme kinetic studies. Kinetic analyses of each GOx variant in soluble form was performed using an ABTS assay with different concentrations of glucose from 0.4 to 50 mM. The other components of the reactions were 4.74 nM of Aga2-GOx WT or mutant enzyme, 4.5 µM HRP, 2 mM ABTS in 100 mM Sodium Phosphate
Buffer at pH 7.4. The concentration of HRP used in the kinetic reactions was ~ 1000 times higher than the GOx concentration and was experimentally confirmed not to limit the rate of the reaction. All kinetic studies were performed in triplicates by following the absorbance of the ABTS substrate at 405 nm following processing by the GOx/HRP cascade. Absorbance values were converted to rates of product formation (µM s -1 H202 ) using a standard curve. Enzyme kinetic data were fitted to the Michaelis-Menten equation using the GraphPad Prism 5 software in order to determine the Km and kcat values for each enzyme variant. The molar concentration of Aga2-GOx WT and M1, M2, and M3 mutants was set to 4.74 nM for each reaction using the Lambert-Beer law and considering the extinction coefficient at 280 nm based on the amino acid sequence of the respective proteins.
Thermostability studies. The thermostability of soluble wild-type and mutant GOx enzymes was determined by incubating 50 ng of each enzyme in 50 mM sodium phosphate buffer (pH 7.4) at increasing temperatures from 50 to 62.5 for 10 minutes. The sample was then cooled and residual activity of GOx was measured using the ABTS assay as described above. For each reaction the initial rate was calculated in the linear range of the curve. For each enzyme variant, the rate of the reaction catalyzed by that sample incubated at 50°C was considered 100% of activity; in order to calculate the residual activity, the initial reaction rates at the various temperatures were normalized to the initial rate at 50°C for the same protein. Additionally, temperaturedependent differential scanning fluorescence was performed using the Prometheus instrument (NanoTemper).
Samples of 0.1 mg/mL wild-type or GOx enzyme were analyzed in microcapillaries in 50 mM sodium phosphate buffer, pH 7.4.
Results and Discussion
GOx is a 160 kDa highly glycosylated homodimeric complex that binds 2 FAD cofactor molecules within a globular folded structure. During its catalytic cycle, GOx utilizes molecular oxygen as an electron acceptor, oxidizing ß-D-glucose to D-gluconolactone and producing hydrogen peroxide as a byproduct (Swoboda and Massey, 1965 ) ( Figure 1A) . We developed the current system relying on GOx and HRP working in tandem as a bi-enzymatic initiation system for polymerization of phenolated fluorescent macromonomers (Sakai et al., 2012; Sakai et al., 2013; Shoda et al., 2016; Sigg et al., 2011; Uyama et al., 1997; Vanella et al., 2019; Zavada et al., 2016) . To produce the macromonomers, we modified sodium alginate (MW = 70,000 g/mol) with tyramine and aminofluorescein ( Figure 1B ) Sakai and Kawakami, 2007) using carbodiimide activation chemistry. 1 H-NMR confirmed the presence of aromatic phenol and fluorescein groups in the resulting polymer (Vanella et al., 2019) . The approach for directed evolution of GOx is presented in Figure 1C . We PCR amplified the full length GOx gene sequence from the genome of Aspergillus niger and cloned it into the pYD1 yeast display vector in frame with the a-agglutinin protein Aga2p. The sequence was confirmed by Sanger sequencing and the plasmid was transformed into S. cerevisiae EBY100 . EBY100 contains a genomic copy of Aga1p under control of a strong galactose promoter (pGAL). The GOx gene was contained on an episomal pYD1 plasmid also under control of the pGAL promoter and located downstream and in frame with the Aga1p domain. EBY100 is advantageous for GOx directed evolution because it supports glycosylation and can display large proteins (Gonzalez-Perez et al., 2012) . Indeed, this strain was previously used for GOx directed evolution using a multi-phase system for reaction compartmentalization (Ostafe et al., 2014) . By supplementing the growth media with galactose, we induced a chromosomal copy of Aga1p and a plasmid copy of Aga2p-GOx. Immunostaining using anti- We next implemented the hydrogel encapsulation system for the isolation of GOx variants with enhanced properties. We targeted mutagenesis to the N-terminus of GOx, which accounts for the dimer interface. We applied a random mutagenesis approach, generating a pool of GOx mutants through error prone PCR targeting the first 500 nucleotides of the gene. This mutagenized PCR product was then transformed directly into yeast together with the linearized pYD1 plasmid and assembled in vivo by gap repair. We estimated the size of the library by counting the number of colonies per area on a representative area of the agar plates and multiplying by the total area of all the plates, obtaining an approximate library size of one half million GOx variants (~ 0.5 10 6 ). By sequencing the plasmids of 5 randomly selected clones from the yeast library, we calculated an average mutation frequency of 8 mutations per kb.
In order to screen the library, we disrupted the structure of GOx homodimers using high concentrations of gaunidinium hydrochloride (GdnHCl). We found that short term exposure to 5M GdnHCl followed by washing in PBS buffer irreversibly denatured the parent GOx enzyme resulting in complete inhibition of the cellular encapsulation reaction. Treatment of the yeast cells with 5M GdnHCl additionally resulted in partial cell death, with ~25% of the cells surviving and propagating in growth media without requiring plasmid extraction or re-transformation. This screening strategy allowed us to exclude clones that performed as well as or worse than wild type GOx, while maintaining a significant number of living cells capable of being isolated and expanded in culture. In the absence of GdnHCl, we observed no adverse effects of the gel capsules on cell growth following encapsulation (Vanella et al., 2019) . Encapsulated cells were able to easily break out of the gel capsules and propagate in growth media.
The screening procedure involved incubation of the mutant GOx library with 5M GdnHCl for 10 minutes, followed by washing and addition of hydrogel encapsulation reagents to the cell mixture in a one-pot reaction. This approach assayed for residual GOx activity following GdnHCl treatment, whereby the presence of the hydrogel shell was correlated with more active or more stable GOx variants displayed on the cell wall.
All cells trapped in fluorescent alginate and not stained by propidium iodide (PI), a fluorescent dye used to label the dead cells, were isolated through single cell sorting and recultured for subsequent protein expression and characterization ( Figure S1 ).
The ultrahigh throughput nature of the 10-min one-pot encapsulation method allowed the analysis of more than 5 10 6 library members in a single sorting session of less than 1 hour, providing ~10-fold coverage of the mutant library of size 0.5 10 6
. Selected cells were re-cultured and tested individually to compare the stability and activity of the displayed GOx variants to the parent enzyme. Following screening, the residual activity of 27 mutants along with wild type GOx was first tested in the cell display format. Each isolated clone was induced for GOx expression and incubated at elevated temperature as follows. Each clone was exposed to 10 minutes of thermal stress at 70 °C, followed by exposure to the hydrogel encapsulation reagents. The fraction of encapsulated cells was then analyzed using flow cytometry (data not shown). The three GOx mutants that performed best under thermal stress in the cell surface-based assay were then purified as soluble Aga2-GOx fusion proteins and further analyzed. The obtained parental Aga2-GOx and the three mutant Aga2-GOx enzymes are denoted WT, and M1, M2, and M3, respectively. It was previously reported (Blazic et al., 2013 ) that Aga2-GOx fusion proteins produced using surface display in S. cerevisiae exhibited a ~ 1.5-fold decrease in catalytic turnover rate as compared with GOx lacking the Aga2 fusion domain. This prior work confirmed, however, that both an enhanced mutant and wild type GOx were affected equally by fusion with Aga2, indicating that detection of an improved GOx variant as an Aga2-fusion reflects improvement in the properties of the enzyme and not an artifact of the Aga2 fusion domain.
The three evolved mutants (M1, M2, M3) and WT enzyme were released from their respective cell surfaces using dithiothreitol (DTT) to reduce the disulfide bonds between Aga1p and Aga2p-GOx. Soluble
Aga2-GOx was then purified from the reduced cell supernatants using ion exchange chromatography. The resulting proteins were tested for kinetic parameters using a cascade HRP/ABTS assay ( Figure 3A) . All three mutants exhibited improved activity ( Figure 3B) , with M1 having 4.9-fold greater catalytic efficiency. M3
exhibited the highest kcat value, which was 3.96-fold higher than WT. The Km values for M1, M2, and M3 were furthermore slightly lower than WT but not hugely improved. This was consistent with the selection step which was performed at a saturating substrate concentration of 100 mM glucose.
Sequence analysis (Figure 3B) showed that the improvements in enzyme activity were achieved as a result of a single point mutation in the case of M1 and M3, or as the result of 2 mutations close together in primary sequence in the case of M2. Each mutant presented a mutation which replaced a Leucine with Proline in position 9 or 13. In addition, M2 contained an additional mutation that replaced the Alanine at position 16 with Threonine. The identified mutations were all located within the first 22 amino acids of the GOx protein leader peptide sequence. This region of the protein is cleaved off when the enzyme is expressed natively in A.
niger. To the best of our knowledge, prior work on directed evolution of GOx in heterologous systems excluded the leader sequence, therefore the mutations identified here are newly reported sequences (Holland et al., 2012; Ostafe et al., 2014; Prodanovic et al., 2011; Zhu et al., 2007) .
Thermostability of the evolved mutants was evaluated by measuring normalized initial substrate turnover rate following 10 minute heat shock ( Figure 3C ). All three enzymes showed improvement in thermostability, with the largest improvement occurring at 55 °C, where the WT enzyme exhibited 59% residual activity while M1, M2, and M3 remained 74, 73, and 72% active, respectively. Thermostability of WT, M1, M2 and M3 was further analyzed using nano differential scanning fluorescence (nanoDSF) (Figure   4 ). NanoDSF determines protein denaturation temperature by monitoring the normalized intrinsic fluorescence ratio (350 nm / 330 nm) excited at 280 nm as a function of temperature. The nanoDSF results showed two denaturation peaks occurring at 53°C and 61 °C. For mutants M1 and M3, the peak at 61°C was significantly more prominent than the one at 53 °C, indicating a larger fraction of the sample denatured at the higher temperature. For mutant M2, the peaks at 61 °C and 53 °C were equally prominent. For wild type by contrast, the peak at 53°C was the dominant peak. This result indicates that the mutants exhibit a thermally stabilized dimer conformation that outperforms WT. Combining this result with SDS-PAGE analysis (see below), we attributed the lower temperature denaturation peak at 53°C to denaturation of GOx monomers, and the higher temperature denaturation peak at 61°C to denaturation of GOx dimers.
We hypothesized that changes in GOx glycosylation resulting from the selected mutations could be responsible for the enhanced activity and thermal stability. With the introduction of a threonine residue, the A16T mutation in M2 introduces a candidate residue for O-linked glycosylation. The other isolated mutations resulted in introduction of a proline in place of leucine at position 9 or 13 ( Figure 3B ) directly adjacent to a serine residue, which is also a potential O-linked glycosylation site (Kukuruzinska et al., 1987) . We found that digestion of WT, M1, M2, and M3 glycoproteins using endoglycosidase-H to cleave N-linked high mannose chains resulted in differently sized bands for M1-M3 as compared with WT when analyzed using SDS-PAGE (Figure 5) , suggesting that O-linked glycosylation of the mutants conferred activity and stability enhancement.
Since availability for glycosylation depends on structure, we can speculate that the L9P and L13P mutations resulted in disordering of the alpha helix linker region and improved accessibility of the adjacent serine residues for O-mannosyltransferases, resulting in stabilization of the dimerized form of GOx.
Conclusion
We presented a system where localized GOx-mediated hydrogel polymerization at the cell surface provided an artificial cell phenotype that was utilized for directed evolution of the enzymatic initiator. The technique allowed screening of GOx libraries using one-pot encapsulation reactions in homogeneous medium.
The screening procedure consisted of only 10 minutes incubation of the mutant library followed by washing and flow cytometric sorting, without requiring additional reaction compartmentalization or robotic sampling.
The potential throughput for screening enzymes is limited in this case only by the speed of flow cytometry (~10 7 cells/hour). This level of throughput significantly accelerates the enzyme screening step as compared to competing methods. In addition to GOx, other classes of enzymes are compatible with similar reaction schemes to achieve cross-linking of synthetic hydrogels for directed evolution, including other oxidoreductases, peroxidases, and laccases. We validated our system by screening and successfully isolating several stable GOx mutants exhibiting up to 4.9-fold higher catalytic efficiency which was achieved through large improvements of kcat and comparatively smaller improvements in Km. We characterized the differences in thermal stability and glycosylation profiles of the mutant enzymes to account for their ability to outperform the wild type under the assay conditions. Previously, a mutant Aga2-GOx called B11 was purified and characterized (Blazic et al., 2013) (positive for encapsulation in fluorescent alginate hydrogel and negative for PI) were sorted and recultured for the isolation of the evolved enzymes.
